Blog

Stories from the Front Lines
of Regenerative Care

Explore the science, stories, and clinical insights behind regenerative veterinary medicine—where innovation meets real-world care.

Regenerative Medicine in Veterinary Practice: Perceptions, Experience, and Outlook

Regenerative medicine is evolving rapidly in humans and pets, and the first FDA-approved mesenchymal stromal cell (MSC) therapy in veterinary medicine is anticipated in 2026, targeting refractory feline chronic gingivostomatitis. To learn how veterinary professionals are navigating the evolving regenerative medicine landscape, Gallant collaborated with the American Animal Hospital Association (AAHA) to conduct this survey….

Regenerative Medicine

Feline Chronic Gingivostomatitis (FCGS)

Feline Osteoarthritis (OA)

Canine Osteoarthritis (OA)

Canine Atopic Dermatitis

Feline Chronic Kidney Disease

Clinical Research & Innovation

Regenerative Medicine

Feline Chronic Gingivostomatitis (FCGS)

Feline Osteoarthritis (OA)

Canine Osteoarthritis (OA)

Canine Atopic Dermatitis

Feline Chronic Kidney Disease

Clinical Research & Innovation